Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer [Phase 1, Phase 2]
PLX2853 was evaluated as a single agent and in combination with carboplatin in platinum-resistant epithelial ovarian cancer and other gyneco…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of Maplirpacept in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer was terminated, …
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers [Phase 1]
This document reports a Phase 1 clinical trial of NI-1801 for mesothelin-expressing solid cancers, with recruiting status and multiple indic…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial of JK08 for unresectable locally advanced or metastatic cancer conducted by Salubris Biotherapeutics is cur…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: The INFLUENCE of Cytoreduction on PRO in EOC
This clinical trial update covers a study on how cytoreduction influences patient-reported outcomes in epithelial ovarian cancer; the trial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer [Phase 1]
A Phase 1 trial assessing the safety and biological activity of IP IMNN-001 (GEN-1) with neoadjuvant chemotherapy in epithelial ovarian canc…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: The Role of CircDENND4C in Epithelial Ovarian Cancer
A clinical trial by Assiut University is investigating CircDENND4C in epithelial ovarian cancer and is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AsiDNA in combination with Olaparib in participants with recurrent solid tumors has completed; the stu…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer Surgery [NA]
Ongoing recruitment for a clinical study comparing rectosigmoid resection versus seromuscular tumor shaving in epithelial ovarian cancer wit…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Cukurova Score Validation Study
A clinical trial at Cukurova University is validating the Cukurova Score for epithelial ovarian cancer and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression [Phase 3]
A Phase 3 study of mirvetuximab soravtansine in platinum-resistant, high-FRα epithelial ovarian, primary peritoneal, or fallopian tube cance…
-
CLINICAL_TRIALS other · 2024-08-06Clinical Trial Update: Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating maintenance therapy with Fluzoparib in combination with Apatinib Mesylate for stage III-IV ovarian cance…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression [Phase 3]
Phase 3 trial comparing mirvetuximab soravtansine with investigator's choice chemotherapy in FRα-high, platinum-resistant epithelial ovarian…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Research on Nutritional Risk Indexes and Inflammatory Indicators in Postoperative Complications and Prognosis of Epithelial Ovarian Cancer Patients
The clinical trial update describes research on nutritional risk indexes and inflammatory indicators as predictors of postoperative complica…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab [Phase 2]
Phase 2 trial evaluating weekly ixabepilone with or without biweekly bevacizumab in epithelial ovarian cancer and related peritoneal cancers…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer [NA]
This clinical trial update discusses the timing of surgery after neoadjuvant chemotherapy for advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib [Phase 3]
Phase 3 rollover study CATCH-R provides continued access to rucaparib for eligible patients with metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer [Phase 1]
This update reports the completion of a Phase 1 study evaluating the safety and feasibility of adding metformin to carboplatin/paclitaxel ch…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: FES-PET to Determine ER-expression in Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial using the FES-PET imaging agent to determine estrogen receptor expression in epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Perioperative Early Tiredness (Acute Fatigue) in Patients With Epithelial Ovarian Cancer
A completed clinical trial update examining perioperative early fatigue in patients with epithelial ovarian cancer, including measurements f…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC [Phase 2, Phase 3]
Phase 2/3 trial evaluating MRD assessment combined with a personalized vaccine to prevent postoperative recurrence in epithelial ovarian can…
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating mirvetuximab soravtansine in combination with bevacizumab, carboplatin, pegylated liposomal doxorubicin, or pem…
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure [Phase 2]
A Phase 2 trial investigating pamiparib for epithelial ovarian cancer after prior PARP inhibitor exposure.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating avelumab with or without entinostat in advanced epithelial ovarian cancer and peritoneal cancer has completed; re…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC). [Phase 2]
Phase 2 trial of pembrolizumab with paclitaxel and carboplatin in advanced epithelial ovarian cancer (and fallopian tube/peritoneal cancers)…